The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 533 KB) and Technical Notes (PDF, 752 KB) pages.


Download and Print: Download Printer-friendly PDF Download data

Table 19.30

All Lymphoid Neoplasms With Detailed Non-Hodgkin Lymphoma Subtypesa

SEERb 5-Year Relative Survival (Percent) by Age at Diagnosis
All Races, Males, 2004-2010
Site All Ages Ages 0-19 Ages 20-64 Ages 65+
Count Percent 95%
Confidence
Interval		 Percent 95%
Confidence
Interval		 Percent 95%
Confidence
Interval		 Percent 95%
Confidence
Interval
Low High Low High Low High Low High
Lymphoid Neoplasm 93,448 67.7 67.3 68.1 88.3 87.3 89.2 73.8 73.3 74.3 57.1 56.3 57.9
1 Hodgkin Lymphoma 8,123 84.4 83.4 85.3 96.8 95.3 97.8 87.7 86.6 88.6 52.6 48.2 56.8
2 Non-Hodgkin lymphoma 82,956 66.5 66.1 67.0 86.3 85.1 87.4 72.1 71.6 72.7 57.8 57.0 58.5
2(a) Non-Hodgkin lymphoma, B-cell 75,497 67.0 66.6 67.5 87.6 86.2 88.9 73.2 72.6 73.8 58.4 57.6 59.2
2(a) 1. Precursor Non-Hodgkin lymphoma, B-cell 3,960 67.9 66.2 69.6 87.2 85.6 88.7 35.3 32.2 38.5 17.1 11.4 23.6
2(a) 2. Mature Non-Hodgkin lymphoma, B-cell 68,370 67.0 66.5 67.5 89.5 86.8 91.7 74.5 73.9 75.1 58.6 57.7 59.4
2(a) 2.1. Chronic/Small/Prolymphocytic/ Mantle B-cell Non-Hodgkin lymphoma 17,804 75.0 73.9 76.0 - - - 83.5 82.3 84.7 68.3 66.7 69.8
2(a) 2.1.1. Chronic/Small lymphocytic leukemia/lymphoma 15,341 78.2 77.1 79.3 - - - 86.5 85.3 87.7 71.8 70.1 73.5
2(a) 2.1.2. Prolymphocytic leukemia, B-cell 69 51.0 34.3 65.4 - - - - - - 48.4 29.1 65.2
2(a) 2.1.3. Mantle-cell lymphoma 2,394 54.9 52.1 57.7 - - - 66.7 63.0 70.2 44.0 39.9 48.0
2(a) 2.2. Lymphoplasmacytic lymphoma/ Waldenstrom macroglubulinemia 1,547 79.4 75.8 82.6 - - - 84.3 79.9 87.9 76.3 71.0 80.7
2(a) 2.2.1. Lymphoplasmacytic lymphoma 660 75.8 69.9 80.7 - - - 79.8 72.3 85.6 73.0 64.3 79.9
2(a) 2.2.2. Waldenstrom macroglubulinemia 887 81.9 77.4 85.6 - - - 87.5 81.6 91.7 77.7 71.2 82.9
2(a) 2.3. Diffuse large B-cell lymphoma (DLBCL) 17,715 60.4 59.4 61.3 89.0 84.1 92.5 67.3 66.2 68.4 50.8 49.2 52.5
2(a) 2.3.1. DLBCL, NOSc 17,539 60.4 59.4 61.3 89.3 84.3 92.8 67.3 66.2 68.4 51.0 49.3 52.6
2(a) 2.3.2. Intravascular large B-cell lymphoma - - - - - - - - - - - - -
2(a) 2.3.3. Primary effusion lymphoma 49 22.0 9.6 37.7 - - - 22.9 9.7 39.4 - - -
2(a) 2.3.4. Mediastinal large B-cell lymphoma 109 78.2 66.1 86.5 - - - 86.5 74.9 93.0 - - -
2(a) 2.4. Burkitt lymphoma/leukemia 1,611 58.9 56.2 61.5 88.8 85.0 91.7 54.9 51.5 58.2 25.2 17.3 34.0
2(a) 2.5. Marginal-zone lymphoma (MZL) 4,068 89.4 87.4 91.1 100.0 - - 91.1 89.1 92.8 87.1 83.5 89.9
2(a) 2.5.1. Splenic MZL 353 86.6 79.1 91.6 - - - 84.6 75.8 90.4 88.2 73.9 94.9
2(a) 2.5.2. Extranodal MZL, MALTc type 2,389 93.1 90.4 95.0 - - - 94.4 91.9 96.1 91.3 85.6 94.9
2(a) 2.5.3. Nodal MZL 1,326 82.8 79.1 85.8 - - - 86.0 81.7 89.4 79.2 73.2 84.0
2(a) 2.6. Follicular lymphoma 8,950 85.5 84.3 86.6 92.5 71.8 98.2 89.2 88.0 90.3 79.4 76.9 81.8
2(a) 2.7. Hairy-cell leukemia 1,176 94.2 91.0 96.2 - - - 97.7 95.5 98.8 83.6 74.1 89.9
2(a) 2.8. Plasma cell neoplasms 15,480 45.8 44.7 46.9 - - - 57.1 55.6 58.6 35.9 34.3 37.4
2(a) 2.8.1. Plasmacytoma 1,092 68.4 64.5 72.0 - - - 78.5 74.1 82.3 52.3 45.3 58.7
2(a) 2.8.2. Multiple myeloma/ plasma-cell leukemia 14,388 44.0 42.9 45.2 - - - 54.9 53.3 56.5 34.9 33.3 36.4
2(a) 2.9. Heavy chain disease - - - - - - - - - - - - -
2(a) 3. Non-Hodgkin lymphoma, B-cell, NOSc 3,167 66.8 64.2 69.1 76.3 49.8 90.1 73.1 70.0 75.9 61.5 57.6 65.2
2(b) Non-Hodgkin lymphoma, T-cell 6,159 62.1 60.6 63.6 82.7 79.8 85.2 63.5 61.6 65.4 48.8 45.4 52.1
2(b) 1. Precursor Non-Hodgkin lymphoma, T-cell 615 62.6 58.3 66.7 83.0 78.1 86.9 43.5 36.8 50.0 - - -
2(b) 2. Mature Non-Hodgkin lymphoma, T-cell 5,500 62.2 60.5 63.8 82.5 78.8 85.7 65.3 63.3 67.2 49.8 46.3 53.2
2(b) 2.1. Mycosis fungoides/Sezary syndrome 1,302 88.5 85.2 91.2 100.0 - - 92.6 89.6 94.7 78.2 69.3 84.8
2(b) 2.1.1. Mycosis fungoides 1,263 89.6 86.2 92.2 100.0 - - 93.4 90.4 95.4 79.6 70.3 86.3
2(b) 2.1.2. Sezary syndrome 39 50.7 30.3 68.0 - - - - - - - - -
2(b) 2.2. Peripheral T-cell lymphoma 3,194 54.4 52.2 56.5 78.5 71.2 84.2 59.1 56.4 61.7 42.7 38.8 46.6
2(b) 2.2.1. Peripheral T-cell lymphoma, NOSc 1,093 36.2 32.6 39.8 56.4 35.9 72.6 39.5 34.8 44.0 29.9 23.9 36.1
2(b) 2.2.2. Angioimmunoblastic T-cell lymphoma 361 37.9 31.6 44.3 - - - 48.8 39.7 57.3 27.0 18.8 36.0
2(b) 2.2.3. Subcutaneous panniculitis- like T-cell lymphoma 28 61.2 18.3 86.7 - - - - - - - - -
2(b) 2.2.4. Anaplastic large cell lymphoma, T-cell or null-cell type 748 56.1 52.0 59.9 84.5 75.8 90.2 57.3 52.3 62.0 31.8 23.2 40.7
2(b) 2.2.5. Hepatosplenic T-cell lymphoma 29 24.2 10.1 41.6 - - - - - - - - -
2(b) 2.2.6. Enteropathy-type T-cell lymphoma 37 0.0 - - - - - - - - - - -
2(b) 2.2.7. Cutaneous T-cell lymphoma, NOSc 618 80.4 75.3 84.6 - - - 84.6 78.7 88.9 72.6 61.8 80.8
2(b) 2.2.8. Primary cutaneous anaplastic large cell lymphoma 280 89.8 82.9 94.0 - - - 94.0 87.7 97.1 80.6 64.0 90.2
2(b) 2.3. Adult T-cell leukemia/lymphoma 597 61.5 56.8 65.8 83.9 79.0 87.7 38.8 31.0 46.4 9.6 1.7 26.2
2(b) 2.4. NKc/T-cell lymphoma, nasal-type/ agressive NKc-cell leukemia 269 41.5 34.5 48.3 - - - 39.2 31.3 46.9 39.0 24.6 53.2
2(b) 2.5. T-cell large granular lymphocytic leukemia 65 52.2 35.1 66.8 - - - 72.5 47.3 87.1 38.1 18.3 57.8
2(b) 2.6. Prolymphocytic leukemia, T-cell 73 21.6 11.4 34.0 - - - 31.3 16.1 47.8 10.0 1.8 26.8
2(b) 3. Non-Hodgkin lymphoma, NOSc , T-cell 44 44.9 27.5 60.9 - - - - - - - - -
2(c) Non-Hodgkin lymphoma, unknown lineage 1,300 58.3 55.1 61.3 83.4 79.0 87.0 53.1 48.2 57.8 40.5 34.3 46.7
2(c) 1. Precursor lymphoblastic leukemia/ lymphoma, unknown lineage 596 63.7 59.5 67.7 83.8 79.4 87.4 33.7 25.8 41.7 23.4 13.0 35.6
2(c) 2. Prolymphocytic leukemia, unknown lineage 32 38.2 20.4 56.0 - - - - - - - - -
2(c) 3. Non-Hodgkin lymphoma, NOSc, unknown lineage 672 53.9 49.1 58.5 - - - 62.6 56.5 68.1 44.4 37.0 51.5
2(*) 1. Total precursor lymphoma/leukemiad 5,171 66.9 65.4 68.3 86.4 85.0 87.7 36.7 34.0 39.4 17.5 12.7 22.9
3 Composite Hodgkin lymphoma and Non-Hodgkin lymphoma 45 69.6 49.6 82.9 - - - 65.6 44.7 80.2 - - -
4 Lymphoid neoplasm, NOSc 2,324 49.4 46.7 52.0 82.9 65.8 91.9 59.0 55.4 62.3 39.7 35.8 43.5

Footnotes:

a Morton LM, Turner JJ, Cerhan JR, Linet MS, Treseler PA, Clarke CA, Jack A, Cozen W, Maynadié M, Spinelli JJ, Costantini AS, Rüdiger T, Scarpa A, Zheng T, Weisenburger DD.  Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood. 2007;110:695-708.

b SEER 18 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey, Los Angeles, Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, Louisiana, New Jersey and Georgia excluding ATL/RG).

c NOS = Not otherwise specified. MALT = Mucosa-associated lymphoid tissue. NK = Natural killer.

- Statistic not displayed due to less than 25 cases.

Page Navigation: << Previous Next >>

The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.